Hope Funds for Cancer Research is offering fellowships to postdoctoral scientists who propose to work on highly innovative research projects that challenge the traditional paradigms of understanding the causes, mechanisms, progression, disease markers or risk factors of the most difficult-to-treat cancers, including pancreatic, lung, liver, sarcomas, esophageal, brain, gastric, bone and ovarian cancers; and rare leukemias, lymphomas and MDS. The Trustees of the Hope Funds believe that funding research that could lead to breakthroughs in these areas and increase life expectancy in these types of cancers is at the core of its mission. The Fellowship Review Committee will consider each of the following criteria, with a strong emphasis on the innovation of the project, in evaluating candidates.
The Hope Funds for Cancer Research is awarding three-year fellowships with a stipend of $56,000 for the first year, $59,000 for the second year, and $62,000 for the third year. A travel grant of $1,500 will be awarded each year to each grantee for the purpose of attending conferences and/or scientific training meetings. All awards and stipends are made to the Institution for the support of the designated Fellow.
Hope Funds for Cancer Research does not permit deductions to cover administrative expenses from either stipend/fellowship or travel grants as a matter of policy. Supplementation of stipends is permitted from either Institution or Sponsor’s grants, but not by any other fellowship awards or grants. The total stipend should not exceed the level of support for other professionals at the same level of training in that institution. The Hope Funds for Cancer Research’s grants are intended for full-time research. The candidates must devote their principal time and effort to the Funds-supported research activities. Any activities in addition to this Fellowship should be clearly specified in the application and in the annual progress report. Fellows are not permitted to pursue additional degrees during the course of their fellowship. Should the Fellow and/or Sponsor wish to discontinue the project, leave the Institution or modify any aspect of the award, he or she must seek approval from the Hope Funds for Cancer Research in advance. Failure to comply with this requirement may jeopardize any future awards to Institution and/or Sponsor by the Fund.
Hope Funds for Cancer Research pays fellowships quarterly to the Institution. These fellowships do not constitute an employer-employee relationship between the Hope Funds for Cancer Research and the Fellow. Detailed annual scientific progress reports are due annual (months 12, 24 and 36), and informal progress reports are due at the ends of months 5, 17, and 29. Financial Reports are due annually.
The invention policy of the Hope Funds for Cancer Research requests adherence by the Fellow to the established patent policy of the Institution where he/she is working. For any discovery made that was funded in any part by a Hope Funds for Cancer Research grant, the Institution shall provide written notification to Hope Funds for Cancer Research within ninety (90) days of the disclosure of any patentable technology, filing of a patent application, or issuance of a patent. In addition, Institutions Technology Transfer Office shall provide a yearly report of the status of the patenting and licensing efforts for each disclosed technology.
In addition, the following documents (PDF) are required of grant awardees:
1. Strong Scientific Significance & Relevance
The most critical driver of success is proposing research that addresses important problems in cancer detection, treatment, control, or prevention — especially those aligned with SWOG’s mission of improving clinical cancer outcomes. Projects should show a clear rationale that the research will meaningfully advance understanding or clinical practice.
📌 What reviewers look for:
Clear definition of a critical barrier in cancer research
Demonstrated potential to advance cancer science or care
Relevance either to clinical trials or translational pathways
2. Innovation & Novelty
A core review criterion across Hope Foundation-funded mechanisms (including SEED and Impact Awards) is innovation — proposing ideas or methods that go beyond routine incremental research. Projects that could challenge current paradigms or open new avenues for research tend to score higher.
📌 What this means in practice:
Novel therapeutic approaches, biomarkers, or trial designs
Methods that could enable future clinical trials
Early exploratory research with potential for translational impact
3. Investigator Qualifications & Team Strength
Review panels assess whether the PI and collaborators have the experience, expertise, and track record to execute the project successfully. This includes evidence of relevant publications, prior research accomplishments, and complementary skills within the team.
📌 Positive signals include:
Established research record in oncology (clinical, translational, or methodological)
Prior involvement in cooperative group (SWOG) research
Experienced collaborators, particularly when projects are interdisciplinary
4. Strong Research Approach & Feasibility
Reviewers evaluate the conceptual framework, study design, methods, and analytical plan in a manner closely aligned with NIH peer review criteria (significance, innovation, approach, investigators, and environment). A well-reasoned approach with realistic milestones increases the likelihood of success.
📌 Key success factors:
Well justified methods appropriate to the aims
Consideration of alternative strategies and risk management
Evidence that the study can be completed in the proposed timeframe
5. Appropriate Research Environment & Institutional Support
Grants from Hope Foundation mechanisms consider whether the institution where the research will be conducted provides a supportive and high-quality environment — including access to necessary resources, infrastructure, and collaborators.
📌 Environmental indicators of success:
Strong mentorship (especially for early career researchers)
Laboratory or clinical resources appropriate to the project
Institutional commitment to the research area
6. Alignment with SWOG’s Mission (for SWOG/Hope Awards)
Many Hope Foundation awards (e.g., SEED, Impact Awards) specifically fund research that will inform future SWOG clinical trials or derive value from completed SWOG studies. Projects that clearly support SWOG’s network goals in cancer clinical trials are especially competitive.
📌 What this looks like:
Secondary analyses of SWOG clinical trial data
Exploratory translational studies directly tied to future trial concepts
Research designed to strengthen SWOG committee portfolios
A. Early/Exploratory Projects with Potential for Future Funding
Programs such as the SWOG Early Exploration & Development (SEED) Fund encourage pilot or early-stage work that can lead to larger extramural research grants. Demonstrating that your project is a strong stepping stone toward broader funding increases competitiveness.
B. Clear Research Impact and Translation Pathway
Even high-risk or exploratory projects succeed more when applicants can articulate how the outcomes might directly inform clinical practice, future trials, or broader cancer research goals — especially when traditional funding might not yet support the idea.
| Predictor | Why it Matters |
|---|---|
| Clear scientific significance | Demonstrates direct impact on cancer science or care |
| Innovation & risk-taking | Signals potential for breakthroughs |
| Strong investigator/team profile | Builds confidence in execution and publication |
| Sound methods & feasibility | Ensures project can be completed as proposed |
| Supportive research environment | Provides infrastructure and mentorship |
| Alignment with SWOG mission | Enhances relevance to Hope Foundation priorities |
Eligible Countries:
Sponsor Institute/Organizations: Hope Foundation for Cancer Research
Sponsor Type: Corporate/Non-Profit
Address: 24 Frank Lloyd Wright Drive
Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.
Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.
Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.
Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.
Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.
Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.
Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.
Jan 25, 2026
Jan 25, 2026
$56,000
Affiliation: Hope Foundation for Cancer Research
Address: 24 Frank Lloyd Wright Drive
Website URL: https://www.hope-funds.org/grants/eligibility-and-application/
Disclaimer:It is mandatory that all applicants carry workplace liability insurance, e.g., https://www.protrip-world-liability.com (Erasmus students use this package and typically costs around 5 € per month - please check) in addition to health insurance when you join any of the onsite Trialect partnered fellowships.